Breadcrumb Home Gilead Sciences Politics & Policy PBM bills drove lobbying spending in 2023 Safety Net Hospitals Hospital groups worry as more drugmakers limit 340B discounts Payment Cigna paying members to use biosimilars draws providers ire Supply Chain Hospitals can purchase remdesivir directly from distributor Mergers & Acquisitions Gilead Sciences buying Immunomedics in $21 billion deal Government FDA allows emergency use of drug for coronavirus Government FDA to fast-track COVID-19 therapies Hospitals Chicago-area hospitals begin COVID-19 drug trial Supply Chain Race for COVID-19 treatments reignites debate over role of public funding Opinion Another half-measure for preventing HIV/AIDS transmission Load More Sponsored Content
